Skip to content
Trial Eligibility
Menu

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

NCT06989320

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Kidney Stones
  • Kidney Calculi
  • Urolithiasis
  • Urolithiasis, Calcium Oxalate
  • Nephrolithiasis
  • Nephrolithiasis, Calcium Oxalate
  • Oxalate Urolithiasis
  • Healthy
  • Healthy Volunteer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 80 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Alabama at Birmingham
Last updated on ClinicalTrials.gov
August 27, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • United States, Alabama University of Alabama at Birmingham · Birmingham, AL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.